Transporter-Mediated Interaction

Transporter-mediated interaction describes drug-drug competition for active transport mechanisms altering pharmacokinetics. P-glycoprotein competition increases substrate bioavailability. Organic anion transporter saturation reduces drug clearance. Metabolite transporter interaction causes accumulation. Regulatory consideration addresses transporter interactions.

Bioavailability assessment accounts for transporter effects. Drug combination evaluation identifies interaction risk. Regulatory submissions address interaction prediction. Post-approval monitoring identifies unexpected interactions. Clinical monitoring detects interaction manifestation.